Loading...
NPI 1295738375 · Springfield, OR · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Oregon Surgicenter LLC is a ambulatory surgical clinic/center provider located in Springfield, Oregon. This profile covers 21 Medicare and 11 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Oregon Surgicenter LLC |
| Address | 2400 Hartman Ln |
| City | Springfield |
| State | OR |
| ZIP | 97477 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | May 23, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $1.8M |
| Medicare | $1.4M |
OREGON SURGICENTER LLC bills as an Ambulatory Surgical Clinic/Center and its CPT mix is heavily urology-focused: the top procedures across both payers are cystourethroscopy and related endoscopic stone/stenosis procedures such as 52000, 52356, 52310, 52332 and procedure-level services like 74420 and C9740. The presence of J0585 (onabotulinumtoxinA) and 52287 (neurolytic bladder injection) alongside high-volume cystoscopic codes indicates the ASC performs both diagnostic/therapeutic endoscopy and office-based injectable treatments for lower urinary tract disorders.
This facility reports Total Medicare revenue of $1.4M and Total Medicaid revenue of $1.8M, so Medicaid is the slightly larger payer by reported lifetime revenue but the practice serves both programs at scale rather than being effectively single-payer. Analysts should treat this as a dual-payer outpatient surgical center with meaningful activity on both Medicare and Medicaid.
Revenue concentration differs sharply by payer: the precomputed top 3 Medicare codes account for 42.9% of the provider's Medicare revenue, indicating a moderate concentration of revenue among a few high-value Medicare codes. By contrast, the precomputed top 3 Medicaid codes account for 89.8% of Medicaid revenue, signalling extreme revenue concentration on three Medicaid procedures and greater exposure to changes in coverage or reimbursement for those specific services.
At the Medicare level the highest-revenue procedure codes include 52000 (16.3% of Medicare revenue), 52356 (14.9%), and C9740 (11.7%), and several of these rank at extreme national percentiles: 52000 ranks #21 of 8548 providers nationally (100th percentile; extreme outlier) and 52356 ranks #10 of 3090 providers nationally (100th percentile; extreme outlier). Those rankings indicate national-scale volume for specific cystoscopic/ureteroscopic services rather than a broadly distributed inpatient or multi-service profile.
On the Medicaid side the operation is a dominant in-state provider for core endoscopic urology services: 52000 (4K claims, $578.3K revenue, 32.6% of Medicaid revenue), 52310 (1.2K claims, $518.8K revenue, 29.2%), and 52356 (411 claims, $498.1K revenue, 28.0%) are all listed as rank #1 in-state where available. This suggests the center is the primary destination in Oregon for outpatient cystoscopy and ureteroscopy procedures billed to Medicaid, producing a concentrated competitive advantage in those services at the state level.
Competitive standing is mixed by code: multiple codes show notably above-typical or extreme outlier national volume (examples include Medicare 52000, 52356 and Medicaid 52000, 52310, 52356), while many other listed CPTs are at typical or unremarkable percentiles. That pattern is consistent with a targeted, high-volume niche practice that dominates specific urologic endoscopy procedures rather than a facility with uniformly high volume across a broad set of ambulatory services.
Clinical and operational implications from the code mix include a heavy procedural focus on stone disease and ureteral management (52356, 52332, 52310) together with retrograde imaging (74420) and bladder-directed therapies (52287, J0585). Payers and network planners should note the mix implies dependence on endoscopy-equipped ORs and urology-trained staff, and potential sensitivity to policy changes that affect reimbursement or utilization of cystoscopic and ureteroscopic interventions.
The provider has an established enrollment history (NPI enumerated 2005-05-23 (~21 years ago)), indicating long tenure in the market. Note that code 55700 is present in both Medicare and Medicaid lists but marked as deleted December 31, 2025, so historical billing will include now-deprecated codes and analysts should be cautious when comparing periods that span the deletion date.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
21 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 1,020 | $220 | $226.6K |
| 52356 | The provider performs a cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 120 | $1,790 | $207.8K |
| C9740 | Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants | 30 | $6,050 | $163.2K |
| 55700 | Code deleted December 31, 2025. | 170 | $680 | $114.8K |
| 52332 | The provider performs cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 120 | $940 | $108.7K |
| 52310 | The provider performs a simple cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra… | 150 | $700 | $106.2K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 14,500 | $10 | $72.5K |
| 52287 | The provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystoscope. He then inserts a needle and injects a neurolytic drug into the… | 100 | $680 | $67.7K |
| 51715 | In this procedure, the provider injects a natural or synthetic material into the submucosal tissue of the urethra and or bladder neck using an endoscope, a stiff or flexible tubular instrument with a… | 30 | $1,700 | $44.2K |
| 52234 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 40 | $1,230 | $43.1K |
Showing 1–10 of 21
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
11 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 4,020 | $140 | $578.3K |
| 52310 | The provider performs a simple cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra… | 1,160 | $450 | $518.8K |
| 52356 | The provider performs a cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 410 | $1,210 | $498.1K |
| 74420 | The provider images the urinary tract by performing a retrograde urography, also known as a retrograde pyelography in which he inserts the radiopaque contrast material through a catheter so that it… | 1,010 | $110 | $113.5K |
| 52332 | The provider performs cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 30 | $770 | $25.3K |
| 55700 | Code deleted December 31, 2025. | 70 | $320 | $21.1K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 30 | $340 | $10.4K |
| 52287 | The provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystoscope. He then inserts a needle and injects a neurolytic drug into the… | 40 | $250 | $9.6K |
| 76872 | The provider inserts an ultrasound probe into the rectum and performs a transrectal ultrasound to assess disorders of the prostate, rectum, and surrounding tissues. | 30 | $30 | $1.1K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 1,220 | $0 | $0 |
Showing 1–10 of 11
How this provider's Medicaid billing volume and revenue compare to other Oregon providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Oregon median
11 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 52310 | The provider performs a simple cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra… | 1 | 10 | 1,160 | $450 | $519.2K |
| 52356 | The provider performs a cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 1 | 10 | 410 | $1,210 | $498.3K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 19 | 20 | 470 | $460 | $398.7K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 1 | 20 | 60 | $140 | $57.4K |
| 74420 | The provider images the urinary tract by performing a retrograde urography, also known as a retrograde pyelography in which he inserts the radiopaque contrast material through a catheter so that it… | 1 | 10 | 20 | $110 | $37.8K |
| 55700 | Code deleted December 31, 2025. | 1 | 10 | 70 | $310 | $21.1K |
| 52332 | The provider performs cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 1 | 10 | 20 | $580 | $13.4K |
| 52287 | The provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystoscope. He then inserts a needle and injects a neurolytic drug into the… | 1 | 10 | 30 | $210 | $5.8K |
| 76872 | The provider inserts an ultrasound probe into the rectum and performs a transrectal ultrasound to assess disorders of the prostate, rectum, and surrounding tissues. | 1 | 10 | 30 | $30 | $1.1K |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 5 | 20 | 250 | $1 | $10 |
Showing 1–10 of 11
Other providers in the same ZIP code as Oregon Surgicenter LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.